Exploring Key Insights of the Diabetic Kidney Disease Market: Growth Prospects, Emerging Trends, and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the diabetic kidney disease market?
The market size for diabetic kidney disease has seen substantial growth in recent years. The market is projected to expand from $2.67 billion in 2024 to $2.81 billion in 2025, with a compound annual growth rate (CAGR) of 5.2%. The surge in the historical era can be linked to early comprehension of diabetes complications, progress in diagnostic methodologies, the creation of ACE inhibitors and ARBs, clinical assays and treatment procedures, as well as guidelines and disease management protocols.
What will be the diabetic kidney disease market size in the future?
The market for diabetic kidney disease is projected to witness significant expansion in the coming years, rising to a value of $3.56 billion in 2029, with a compound annual growth rate (CAGR) of 6.1%. Potential factors contributing to this expected growth during the forecast period include advancements in personalized medicine and biomarker development, an increase in global diabetes cases, emphasis on disease modifying therapies, the use of telehealth and remote care, along with updates in healthcare policies and reimbursement terms. Key trends anticipated for this forecast period encompass progress in renal replacement treatments, precision medicine tactics, concentration on early detection and diagnosis, advancements in treatment techniques, and an increase in managing comorbidities.
Get your diabetic kidney disease market report here!
https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report
What main drivers are fueling expansion in the diabetic kidney disease market?
The diabetic kidney disease market is set for expansion due to the increasing occurrence of chronic kidney disease (CKD), a long-term ailment causing progressive kidney function loss and resultant complications such as hypertension, anemia, and bone diseases. With the necessity for diagnosis and treatment options in CKD management, the diabetes kidney disease market growth is charged. Data from Kidney Research UK, a leading charity, revealed in June 2023 that approximately 7.2 million people, over 10% of the UK population, suffer from CKD. Of these, 3.25 million are at the most critical stages, while about 3.9 million are in the early, often untreated and symptomless stages. Predicted estimates indicate a potential increase of the CKD patient population in the UK to 7.61 million by 2033. Hence, the escalating occurrence of CKD is a significant driver in the upswing of the diabetes kidney disease market.
What key areas define the segmentation of the global diabetic kidney disease market?
The diabetic kidney disease market covered in this report is segmented –
1) By Type: Type 1 Diabetes, Type 2 Diabetes
2) By Treatment: Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant Inflammation Modulator, Calcium Channel Blockers, Other Treatments
3) By End User: Hospitals, Homecare, Specialty Centers, Other End Users
Subsegments:
1) By Type 1 Diabetes: Autoimmune-Related Diabetic Kidney Disease, Early-Onset Diabetic Kidney Disease
2) By Type 2 Diabetes: Obesity-Related Diabetic Kidney Disease, Late-Onset Diabetic Kidney Disease
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9932&type=smp
Who are the dominant players expanding their reach in the diabetic kidney disease market?
Major companies operating in the diabetic kidney disease market include AstraZeneca plc, Pfizer Inc., Novartis AG, Bayer AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Fresenius SE & Co. KGaA, F. Hoffmann-La Roche AG, Abbott Laboratories, Reata Pharmaceuticals Inc., Merck & Co., Mitsubishi Tanabe Pharma Corporation, Johnson & Johnson pvt. Ltd., Eli Lilly and Company, GlaxoSmithKline plc, AbbVie Inc., Boehringer Ingelheim International GmbH, Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Company Limited
How are evolving market trends shaping diabetic kidney disease Strategies?
Technological progress is a primary trend gaining traction in the diabetic kidney disease market. Businesses in this market are utilizing cutting-edge technologies to maintain their market standing. For example, in August 2022, Bloom Diagnostics, an American diagnostics and healthcare devices company, introduced the Bloom Kidney Test. It’s a novel addition to the Bloom Smart System, offering an assessment of kidney health by detecting cystatin C levels, a reliable measure of kidney function. The system categorises kidney performance into three stages: normal, mildly decreased, and decreased. The Bloom Smart System uses AI and cloud-based algorithms to combine test results with other pertinent patient information like medical history, lifestyle, and symptoms.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9932
Which regions are emerging as leaders in the diabetic kidney disease market?
North America was the largest region in the diabetic kidney disease market in 2024. The regions covered in the diabetic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Analytical Laboratory Instrument Global Market Report 2024
Healthcare Analytical Testing Services Global Market Report 2024
Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
